2,3,7,8-tetrachlorodibenzo-p-dioxin-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway -: Role of the transcription activaton and DNA binding of AhR

被引:245
作者
Ma, Q [1 ]
Baldwin, KT [1 ]
机构
[1] NIOSH, CDC, HELD, TMBB,Mol Toxicol Lab, Morgantown, WV 26505 USA
关键词
D O I
10.1074/jbc.275.12.8432
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of the aryl hydrocarbon receptor (AhR) by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a potent agonist of AhR, induces a marked reduction in steady state AhR, To analyze the mechanism of regulation of ligand-activated AhR, we examined the biochemical pathway and function of the down-regulation of the receptor by TCDD, Pulse-chase experiments reveal that TCDD shortens the half-life (t(1/2)) of AhR from 28 to 3 h in mouse hepatoma cells. Inhibitors of the 26 S proteasome, lacta-cystin and MG132, block the TCDD-induced turnover of AhR. The TCDD-induced degradation of AhR involves ubiquitination of the AhR protein, because (a) TCDD induces formation of high molecular weight, ubiquitinated AhR and (b) degradation of AhR is inhibited in ts20 cells, which bear a temperature-sensitive mutation in the ubiquitin-activating enzyme El, at a nonpermissive temperature. Inhibition of proteasomal degradation of AhR increases the amount of the nuclear AhR.Arnt complex and "superinduces" the expression of endogenous CYP1A1 gene by TCDD, indicating that the proteasomal degradation of AhR serves as a mechanism for controlling the activity of the activated receptor. We also show that deletion of the transcription activation domain of AhR abolishes the degradation, whereas a mutation in the DNA-binding region of AhR or Amt reduces the degradation; these data implicate the transcription activation domain and DNA binding in AhR degradation. Our findings provide new insights into the regulation of TCDD-activated AhR through ubiquitin-mediated protein degradation.
引用
收藏
页码:8432 / 8438
页数:7
相关论文
共 47 条
[1]   Novel inhibitors of the proteasome and their therapeutic use in inflammation [J].
Adams, J ;
Stein, R .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 31, 1996, 31 :279-288
[2]  
Ausubel FM., 1998, CURRENT PROTOCOLS MO
[3]   Regulation of E2F through ubiquitin-proteasome-dependent degradation: Stabilization by the pRB tumor suppressor protein [J].
Campanero, MR ;
Flemington, EK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2221-2226
[4]  
Carver LA, 1997, J BIOL CHEM, V272, P11452
[5]   Structure and functions of the 20S and 26S proteasomes [J].
Coux, O ;
Tanaka, K ;
Goldberg, AL .
ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 :801-847
[6]   Control of cell lineage-specific development and transcription by bHLH-PAS proteins [J].
Crews, ST .
GENES & DEVELOPMENT, 1998, 12 (05) :607-620
[7]   Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytosplasmic proteasome following nuclear export [J].
Davarinos, NA ;
Pollenz, RS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (40) :28708-28715
[8]   INDUCIBLE, RECEPTOR-DEPENDENT PROTEIN-DNA INTERACTIONS AT A DIOXIN-RESPONSIVE TRANSCRIPTIONAL ENHANCER [J].
DENISON, MS ;
FISHER, JM ;
WHITLOCK, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (08) :2528-2532
[9]   DNA binding by the heterodimeric Ah receptor - Relationship to dioxin-induced CYP1A1 transcription in vivo [J].
Dong, LQ ;
Ma, Q ;
Whitlock, JP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (14) :7942-7948
[10]   IMMUNE-SYSTEM IMPAIRMENT AND HEPATIC-FIBROSIS IN MICE LACKING THE DIOXIN-BINDING AH RECEPTOR [J].
FERNANDEZSALGUERO, P ;
PINEAU, T ;
HILBERT, DM ;
MCPHAIL, T ;
LEE, SST ;
KIMURA, S ;
NEBERT, DW ;
RUDIKOFF, S ;
WARD, JM ;
GONZALEZ, FJ .
SCIENCE, 1995, 268 (5211) :722-726